NIAID-Funded Adjuvant Improves Typhoid Vaccine Candidate in Animal

NIAID-Funded Adjuvant Improves Typhoid Vaccine Candidate in Animal

4.8
(757)
Write Review
More
$ 17.00
Add to Cart
In stock
Description

An investigational typhoid vaccine containing a component developed with NIAID funding may overcome some of the shortcomings of available typhoid vaccines, according to a paper published in the journal Vaccine in June.

Intestinal helminth infection impairs oral and parenteral vaccine

Transcriptional correlates of malaria in RTS,S/AS01-vaccinated

Frontiers Polyphosphazenes as Adjuvants for Animal Vaccines and

Mucosal vaccine delivery: Current state and a pediatric

Key roles of adjuvants in modern vaccines - Document - Gale

Adjuvant Development NIAID: National Institute of Allergy and

Mucosal vaccines — fortifying the frontiers

PDF) Reduced immunogenicity of a live Salmonella enterica serovar

Controlled Human Infection Models To Accelerate Vaccine

Phase variable acetylation of lipooligosaccharide modifies

Transcriptional correlates of malaria in RTS,S/AS01-vaccinated

Intestinal helminth infection impairs oral and parenteral vaccine

Vaccines, Free Full-Text

Vaccine Adjuvant Research Programs